308 related articles for article (PubMed ID: 15187130)
1. Characterization of a peptide inhibitor of Janus kinase 2 that mimics suppressor of cytokine signaling 1 function.
Flowers LO; Johnson HM; Mujtaba MG; Ellis MR; Haider SM; Subramaniam PS
J Immunol; 2004 Jun; 172(12):7510-8. PubMed ID: 15187130
[TBL] [Abstract][Full Text] [Related]
2. Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist.
Waiboci LW; Ahmed CM; Mujtaba MG; Flowers LO; Martin JP; Haider MI; Johnson HM
J Immunol; 2007 Apr; 178(8):5058-68. PubMed ID: 17404288
[TBL] [Abstract][Full Text] [Related]
3. Treatment of mice with the suppressor of cytokine signaling-1 mimetic peptide, tyrosine kinase inhibitor peptide, prevents development of the acute form of experimental allergic encephalomyelitis and induces stable remission in the chronic relapsing/remitting form.
Mujtaba MG; Flowers LO; Patel CB; Patel RA; Haider MI; Johnson HM
J Immunol; 2005 Oct; 175(8):5077-86. PubMed ID: 16210611
[TBL] [Abstract][Full Text] [Related]
4. A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells.
Flowers LO; Subramaniam PS; Johnson HM
Oncogene; 2005 Mar; 24(12):2114-20. PubMed ID: 15688010
[TBL] [Abstract][Full Text] [Related]
5. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
RidderstrÄle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.
Delgado M; Ganea D
J Immunol; 2000 Sep; 165(6):3051-7. PubMed ID: 10975815
[TBL] [Abstract][Full Text] [Related]
7. Role of tyrosine 441 of interferon-gamma receptor subunit 1 in SOCS-1-mediated attenuation of STAT1 activation.
Qing Y; Costa-Pereira AP; Watling D; Stark GR
J Biol Chem; 2005 Jan; 280(3):1849-53. PubMed ID: 15522878
[TBL] [Abstract][Full Text] [Related]
8. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
9. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.
Dif F; Saunier E; Demeneix B; Kelly PA; Edery M
Endocrinology; 2001 Dec; 142(12):5286-93. PubMed ID: 11713228
[TBL] [Abstract][Full Text] [Related]
10. Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells.
Park ES; Kim H; Suh JM; Park SJ; Kwon OY; Kim YK; Ro HK; Cho BY; Chung J; Shong M
Mol Endocrinol; 2000 Mar; 14(3):440-8. PubMed ID: 10707961
[TBL] [Abstract][Full Text] [Related]
11. SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.
Tomic S; Chughtai N; Ali S
Mol Cell Endocrinol; 1999 Dec; 158(1-2):45-54. PubMed ID: 10630404
[TBL] [Abstract][Full Text] [Related]
12. Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling.
Pezet A; Favre H; Kelly PA; Edery M
J Biol Chem; 1999 Aug; 274(35):24497-502. PubMed ID: 10455112
[TBL] [Abstract][Full Text] [Related]
13. Insulin induces suppressor of cytokine signaling-3 tyrosine phosphorylation through janus-activated kinase.
Peraldi P; Filloux C; Emanuelli B; Hilton DJ; Van Obberghen E
J Biol Chem; 2001 Jul; 276(27):24614-20. PubMed ID: 11325969
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium bovis bacillus Calmette-Guérin infection promotes SOCS induction and inhibits IFN-gamma-stimulated JAK/STAT signaling in J774 macrophages.
Imai K; Kurita-Ochiai T; Ochiai K
FEMS Immunol Med Microbiol; 2003 Nov; 39(2):173-80. PubMed ID: 14625101
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
16. The tumor suppressor activity of SOCS-1.
Rottapel R; Ilangumaran S; Neale C; La Rose J; Ho JM; Nguyen MH; Barber D; Dubreuil P; de Sepulveda P
Oncogene; 2002 Jun; 21(28):4351-62. PubMed ID: 12080466
[TBL] [Abstract][Full Text] [Related]
17. SHP-2 regulates SOCS-1-mediated Janus kinase-2 ubiquitination/degradation downstream of the prolactin receptor.
Ali S; Nouhi Z; Chughtai N; Ali S
J Biol Chem; 2003 Dec; 278(52):52021-31. PubMed ID: 14522994
[TBL] [Abstract][Full Text] [Related]
18. A three-dimensional model of Suppressor Of Cytokine Signalling 1 (SOCS-1).
Giordanetto F; Kroemer RT
Protein Eng; 2003 Feb; 16(2):115-24. PubMed ID: 12676980
[TBL] [Abstract][Full Text] [Related]
19. A family of cytokine-inducible inhibitors of signalling.
Starr R; Willson TA; Viney EM; Murray LJ; Rayner JR; Jenkins BJ; Gonda TJ; Alexander WS; Metcalf D; Nicola NA; Hilton DJ
Nature; 1997 Jun; 387(6636):917-21. PubMed ID: 9202125
[TBL] [Abstract][Full Text] [Related]
20. 15d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia.
Park EJ; Park SY; Joe EH; Jou I
J Biol Chem; 2003 Apr; 278(17):14747-52. PubMed ID: 12584205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]